10.1016/j.pbb.2011.08.004 Summary Keywords extended-access, GLP-1 agonist, intravenous self-administration, liraglutide, methamphetamine, rats Citation Hrickova M, Demirci SF, Amchova P and Ruda-Kucerova J (2026) GLP-1 agonist liraglutide decreases operant methamphetamine intake in rats under conditions of short- but not extended-access to the drug
Major body tissues, such as the heart and skeletal muscles, depend on fatty acid oxidation as a primary source of energy
Its marketed as a simpler, natural path to GLP-1-style results, but whether that claim holds up merits a closer look
That glucose-dependent action is why GLP-1s rarely cause hypoglycemia unless combined with insulin or sulfonylureas
In summary, retatrutide also known by its development code LY3437943 represents a potentially significant area of investigation in metabolic medicine